AMV: American Vietnamese Biotech Incorporation - Summary | Jitta

American Vietnamese Biotech Incorporation

VNM:AMV

Price
₫1,200.00
Loss Chance
58.3%
0.62JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
594 / 631
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (18)
Recent Business Performance (28)
Financial Strength (57)
Return to Shareholders (5)
Competitive Advantage (15)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 220.10% in the last year
New Share IssuedMore than 50% in 5 years
SG&A to SalesIncreasing
Cash Conversion CycleMore than 1 year
Key Stats
Jitta Score
Jitta Line
0.62
100.00%
4.03
227.37%
COMPANY DESCRIPTION
American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical equipment and medical diagnostic reagents in Vietnam. It also offers sterilizers, pharmacy labeling machines, medical image disc recorders, medical dry films, medical dry film printers, and digital radiology systems; lizer infrared therapy machines; infusion pumps and electric injection pumps; automatic molecular biology testing machines and automatic immunoassay analyzers and reagents; medical equipment, x-ray systems, mobile x-ray systems, mobile c-arm x-ray systems, vantage 3T and 1.5 T systems, portable color ultrasound systems, and CT scan systems; endoscopic cleaning machines; and medical software products. American Vietnamese Biotech Incorporation was founded in 2002 and is headquartered in Ho Chi Minh City, Vietnam.